Balyasny Asset Management LLC West Pharmaceutical Services Inc Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$314.68 - $395.94 $954,739 - $1.2 Million	-3,034 Reduced 42.24%	4,148 $1.37 Million
Q1 2024 May 13, 2024	SELL	$338.27 - $413.0 $69.8 Million - $85.2 Million	-206,343 Reduced 96.64%	7,182 $2.84 Million
Q4 2023 Feb 14, 2024	BUY	$318.29 - $392.21 $2.08 Million - $2.56 Million	6,521 Added 3.15%	213,525 $75.2 Million
Q3 2023 Nov 14, 2023	BUY	$354.9 - $412.41 $73.5 Million - $85.4 Million	207,004 New	207,004 $77.7 Million
Q4 2022 Feb 14, 2023	BUY	$209.34 - $261.61 $4.41 Million - $5.51 Million	21,065 New	21,065 $4.96 Million
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $6.09 Million - $7.14 Million	-15,150 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$363.01 - $468.47 $5.5 Million - $7.1 Million	15,150 New	15,150 $6.43 Million
Q1 2021 May 17, 2021	SELL	$257.29 - $307.53 $7.37 Million - $8.81 Million	-28,646 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$261.16 - $301.66 $5.28 Million - $6.1 Million	-20,208 Reduced 41.36%	28,646 $8.12 Million
Q3 2020 Nov 16, 2020	BUY	$224.99 - $288.02 $8.66 Million - $11.1 Million	38,506 Added 372.11%	48,854 $13.4 Million
Q2 2020 Aug 14, 2020	BUY	$149.8 - $227.17 $1.55 Million - $2.35 Million	10,348 New	10,348 $2.35 Million
Q4 2019 Feb 14, 2020	SELL	$137.6 - $151.21 $410,460 - $451,059	-2,983 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$121.41 - $150.02 $2 Million - $2.48 Million	-16,502 Reduced 84.69%	2,983 $423,000
Q2 2019 Aug 14, 2019	BUY	$111.27 - $125.15 $2.17 Million - $2.44 Million	19,485 New	19,485 $2.44 Million
Q1 2019 May 15, 2019	SELL	$94.53 - $110.2 $785,071 - $915,211	-8,305 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$93.0 - $123.98 $772,365 - $1.03 Million	8,305 New	8,305 $814,000
Q2 2018 Aug 14, 2018	SELL	$83.32 - $101.88 $1.44 Million - $1.76 Million	-17,229 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$85.56 - $102.4 $699,795 - $837,529	8,179 Added 90.38%	17,229 $1.52 Million
Q4 2017 Feb 14, 2018	BUY	$91.65 - $101.65 $350,652 - $388,912	3,826 Added 73.24%	9,050 $893,000
Q3 2017 Nov 14, 2017	BUY	$84.54 - $96.75 $441,636 - $505,422	5,224	5,224 $503,000

Others Institutions Holding WST

# of Institutions

802

Shares Held

64.3M

Call Options Held

294K

Put Options Held

490K

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$3 Billion
0.05% of portfolio
Black Rock Inc. New York, NY

7.58M
Shares

$2.53 Billion
0.06% of portfolio
State Street Corp Boston, MA

3.21M
Shares

$1.07 Billion
0.04% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

3.07M
Shares

$1.02 Billion
1.44% of portfolio
Alliancebernstein L.P. New York, NY

2.6M
Shares

$868 Million
0.27% of portfolio

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account